Gautam Kishore Valecha, MBBS

Gautam Valecha practices at Holy Cross Hospital in Chicago, Illinois, part of Sinai Health System.

Gautam Valecha's NPI, 1235579632, was assigned on June 28, 2013. Gautam Valecha holds New Mexico license MD2020-0359.

Gautam Valecha's primary practice is Holy Cross Hospital, at 2701 W 68th Street, Chicago, IL 60629 in Cook County. The practice phone is (773) 884-9000.

Gautam Valecha's primary practice is Holy Cross Hospital in Chicago, Illinois, part of Sinai Health System. Gautam Valecha is also affiliated with Mount Sinai Hospital. The medical group on file is Sinai Medical Group. Dmand AI also links Gautam Valecha to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gautam Valecha practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Gautam Valecha's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Gautam Valecha is licensed in New Mexico.

CMS data shows 296 Medicare services from Gautam Valecha across 7 procedure codes in 2024, for 109 Medicare patients. Medicare paid $24,655 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 109 Medicare patients who saw Gautam Valecha in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 67% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gautam Valecha's median patient age at 68, with 56% women.

In 2024, Gautam Valecha wrote 248 Medicare Part D claims for 75 patients. 79% of them were for generic drugs. CMS names the drug for 110 of them, across 5 drugs with 11 or more claims each, at $33,318 in total drug cost. In 2023, CMS named 683 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Gautam Valecha for performance year 2024, reported as part of a group. Gautam Valecha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gautam Valecha as offering telehealth.

Dmand AI links 15 papers to Gautam Valecha, published from 2014 to 2021. 2015 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Immunotherapy. Gautam Valecha has published most often in Cureus. Gautam Valecha's most frequent co-authors are Uroosa Ibrahim, MBBS, Adarsh Vennepureddy, MD and Meekoo Dhar, MD.

CMS Open Payments shows 125 general payments to Gautam Valecha from 28 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $647.